Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KRYS - Krystal Biotech launches late-stage study for B-VEC in rare skin disorder

KRYS - Krystal Biotech launches late-stage study for B-VEC in rare skin disorder

Krystal Biotech Inc.
  • Krystal Biotech (KRYS -3.2%) initiates pivotal Phase 3 (GEM-3) trial evaluating topical gene therapy bercolagene telserpavec (B-VEC, previously KB103) for treatment of dystrophic epidermolysis bullosa (DEB) patients.
  • More news on: Krystal Biotech, Inc., Healthcare stocks news
    • Read more ...
Stock Information
Company Name: Krystal Biotech Inc.
Stock Symbol: KRYS
Market: NASDAQ
Website: krystalbio.com
Menu
KRYS KRYS Quote KRYS Short KRYS News KRYS Articles KRYS Message Board
Get KRYS Alerts

News, Short Squeeze, Breakout and More Instantly...